信隆健康
(002105)
| 流通市值：21.83亿 | | | 总市值：21.94亿 |
| 流通股本：3.64亿 | | | 总股本：3.66亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 717,097,027.34 | 359,564,905.91 | 1,187,687,703.11 | 863,891,372.59 |
| 营业总成本 | 725,270,304.61 | 360,133,901.34 | 1,218,348,833.32 | 889,975,473.19 |
| 其他经营收益 | | | | |
| 营业利润 | -12,755,413.63 | -1,124,039.21 | -73,108,451.72 | -29,559,481.58 |
| 利润总额 | 8,915,821.98 | -1,557,799.62 | -67,222,953.34 | -26,515,898.81 |
| 净利润 | 6,735,973.37 | -1,953,836.79 | -67,893,521.67 | -32,379,951.51 |
| 每股收益 | | | | |
| 其他综合收益 | -6,583,998.71 | -5,803,445.63 | -6,399,028.37 | -5,817,296.74 |
| 综合收益总额 | 151,974.66 | -7,757,282.42 | -74,292,550.04 | -38,197,248.25 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 959,667,135.01 | 950,376,757.28 | 965,656,909.32 | 894,908,318.74 |
| 非流动资产: | | | | |
| 非流动资产合计 | 673,873,359.01 | 686,729,389.66 | 698,207,345.15 | 713,498,922.69 |
| 资产总计 | 1,633,540,494.02 | 1,637,106,146.94 | 1,663,864,254.47 | 1,608,407,241.43 |
| 流动负债: | | | | |
| 流动负债合计 | 637,442,682.8 | 624,209,976.79 | 638,172,344.04 | 541,864,295.85 |
| 非流动负债: | | | | |
| 非流动负债合计 | 124,102,301.32 | 148,809,917.33 | 153,848,375.19 | 155,464,707.99 |
| 负债合计 | 761,544,984.12 | 773,019,894.12 | 792,020,719.23 | 697,329,003.84 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 808,151,485.88 | 798,668,083.25 | 804,528,708.81 | 842,010,974.73 |
| 股东权益合计 | 871,995,509.9 | 864,086,252.82 | 871,843,535.24 | 911,078,237.59 |
| 负债和股东权益合计 | 1,633,540,494.02 | 1,637,106,146.94 | 1,663,864,254.47 | 1,608,407,241.43 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 813,112,865.04 | 398,615,646.06 | 1,336,514,806.53 | 1,031,251,426.07 |
| 经营活动现金流出小计 | 753,682,423.52 | 384,286,947.32 | 1,279,119,936.71 | 972,036,606.23 |
| 经营活动产生的现金流量净额 | 59,430,441.52 | 14,328,698.74 | 57,394,869.82 | 59,214,819.84 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 4,746,821.52 | 333,983.93 | 18,138,192.01 | 16,168,638.61 |
| 投资活动现金流出小计 | 31,108,584.43 | 13,420,435.03 | 93,216,843.33 | 73,041,630.55 |
| 投资活动产生的现金流量净额 | -26,361,762.91 | -13,086,451.1 | -75,078,651.32 | -56,872,991.94 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 252,613,509.51 | 123,005,698.52 | 485,850,958.07 | 409,432,468.55 |
| 筹资活动现金流出小计 | 279,752,969.58 | 86,777,677.72 | 508,725,602.97 | 412,417,875.95 |
| 筹资活动产生的现金流量净额 | -27,139,460.07 | 36,228,020.8 | -22,874,644.9 | -2,985,407.4 |
| 汇率变动对现金及现金等价物的影响 | -13,167,467.38 | -2,839,976.96 | -3,630,428.58 | -1,974,011.32 |
| 现金及现金等价物净增加额 | -7,238,248.84 | 34,630,291.48 | -44,188,854.98 | -2,617,590.82 |
| 期末现金及现金等价物余额 | 332,026,030.25 | 373,894,570.57 | 339,264,279.09 | 380,835,543.25 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -7,238,248.84 | - | -44,188,854.98 | - |